Found 133 matching trials
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
PHASE2The primary objective is to demonstrate the non-inferiority of bevacizumab ...
Location
Academic Medical Center, Dept. Ophthalmology
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
PHASE1This study examines two doses of Ranibizumab (0.5mg and 1.0mg) for the trea...
Location
South Coast Retina
Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD
PHASE4The study will evaluate the efficacy and safety of two different dosing reg...
Location
Eye & Ent Hospital of Fudan University
Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
PHASE4The purpose of the investigators study is to look at the visual outcomes of...
Location
The Royal Victoria Hospital and the Montreal Retinal Institute
Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD
PHASE1This is a randomized, double-blind, two-group parallel, positive-controlled...
Location
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
PHASE1This was a prospective, single center, open label, randomized study evaluat...
Location
Multiple Locations
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
PHASE3The purpose of the study is to find out if treatment with an intravitreal i...
Location
Sall Research Medical Center
Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
NAProliferative ischemic retinopathies lead to a formation of abnormal vessel...
Location
University of Lübeck - Department of Ophthalmology
Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)
NAGenetic factors of an individual patient may have an impact on Ranibizumab ...
Location
State Research Institute of Eye Disease of Russian Academy of Medical Sciences
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
PHASE3Macular edema in diabetes, defined as retinal thickening within two disc di...
Location
Bangladesh Eye Hospital & Institute